EUVIMEDEUVIMED entdecken
Crossref

tert -Butoxycarbonyl-Modification Driven Disturbance of Molecular Ordering Enables High-Efficiency Dual Drugs Co-Assembly for Synergistic Tumor Inhibition

Xuequan Zhang, Xiaoxian Zhang, Jiahui Zhu, Tinghua Li, Lianyi Yang, Lei Lei, Fang Wu iD, Bin He iD, Jun Cao iD

ACS Nano · 2025

DOI: 10.1021/acsnano.4c16986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Xuequan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, People's Republic of Ch…. Hauptthemen laut MEDLINE: Paclitaxel, Camptothecin, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Specific Research Project of Guangxi for Research Bases and Talents, Science and Technology Department of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of carrier-free drug delivery systems (CDDS) for tailored drug combinations posed a significant challenge, particularly in achieving efficient co-assembly while maintaining therapeutic efficacy. Herein, we proposed a co-assembly strategy based on molecular engineering. Paclitaxel (PTX) and 7-ethyl-10-hydroxycamptothecin (SN38) were chemically modified with tert-butoxycarbonyl (BOC) groups. The successful incorporation of the BOC groups was confirmed by proton nuclear magnetic resonance and mass spectrometry analyses. Further characterization using polarized light microscopy and X-ray diffraction revealed that this modification significantly reduced the crystallinity of both drugs, while simultaneously disrupting their original ordered stacking structure. Molecular dynamics simulations indicated that BOC modification increased molecular spacing, reduced stacking density, and expanded molecular volume, resulting in a looser molecular packing arrangement. This structural alteration enabled the modified drug molecules to efficiently coassemble with α-tocopherol succinate (α-TOS) into spherical nanoparticles at a nearly predefined mass ratio. The resulting nanoparticles exhibited a high drug loading capacity of 52.66% and remained stable at 4 °C for over 50 days. Notably, these nanoparticles displayed controllable release characteristics at pH 5.0. Both in vitro and in vivo studies demonstrated the BOC-modified drugs retained their bioactivity. When co-assembled with α-TOS, the nanoparticles exhibited a significant synergistic antitumor effect and suppressed tumor metastasis through downregulation of matrix metalloproteinase-9 (MMP-9) expression. This study provided a solid theoretical foundation and innovative approach for the development of CDDS, utilizing molecular-scale regulation for drug co-assembly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelCamptothecinAntineoplastic AgentsAnimalsHumansMiceNanoparticlesCell Line, TumorDrug LiberationMolecular Dynamics SimulationDrug CarriersCell ProliferationDrug SynergismMice, Inbred BALB CDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

cancer therapycarrier-free drug delivery systemsco-assemblycrystallinitymolecular-scale regulationpacking density

Substanzen

PaclitaxelCamptothecinAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, People's Republic of China.

ORCID-Profile: Fang Wu, Bin He, Jun Cao

Förderung

  • Specific Research Project of Guangxi for Research Bases and Talents
  • Science and Technology Department of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, X., Zhang, X., Zhu, J., Li, T., Yang, L., Lei, L., Wu, F., He, B., & Cao, J. (2025). tert -Butoxycarbonyl-Modification Driven Disturbance of Molecular Ordering Enables High-Efficiency Dual Drugs Co-Assembly for Synergistic Tumor Inhibition. ACS Nano. https://doi.org/10.1021/acsnano.4c16986

Vancouver

Zhang X, Zhang X, Zhu J, Li T, Yang L, Lei L, et al. tert -Butoxycarbonyl-Modification Driven Disturbance of Molecular Ordering Enables High-Efficiency Dual Drugs Co-Assembly for Synergistic Tumor Inhibition. ACS Nano. 2025. doi:10.1021/acsnano.4c16986

BibTeX
@article{Zhang2025,
  author = {Zhang, Xuequan and Zhang, Xiaoxian and Zhu, Jiahui and Li, Tinghua and Yang, Lianyi and Lei, Lei and Wu, Fang and He, Bin and Cao, Jun},
  title = {tert -Butoxycarbonyl-Modification Driven Disturbance of Molecular Ordering Enables High-Efficiency Dual Drugs Co-Assembly for Synergistic Tumor Inhibition},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.4c16986}
}
Kostenlos starten →